799
2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1H-pyrazol-1-yl)propanamide
Find entries where: 799
is present as a standalone ligand in 2 entries
Chemical Component Summary | |
|---|---|
| Name | 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1H-pyrazol-1-yl)propanamide |
| Synonyms | taselisib |
| Identifiers | 2-methyl-2-[4-[2-(5-methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]propanamide |
| Formula | C24 H28 N8 O2 |
| Molecular Weight | 460.53 |
| Type | NON-POLYMER |
| Isomeric SMILES | Cc1nc(n(n1)C(C)C)c2cn3c(n2)-c4ccc(cc4OCC3)c5cnn(c5)C(C)(C)C(=O)N |
| InChI | InChI=1S/C24H28N8O2/c1-14(2)32-22(27-15(3)29-32)19-13-30-8-9-34-20-10-16(6-7-18(20)21(30)28-19)17-11-26-31(12-17)24(4,5)23(25)33/h6-7,10-14H,8-9H2,1-5H3,(H2,25,33) |
| InChIKey | BEUQXVWXFDOSAQ-UHFFFAOYSA-N |
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 62 |
| Chiral Atom Count | 0 |
| Bond Count | 66 |
| Aromatic Bond Count | 21 |
Drug Info: DrugBank
| DrugBank ID | DB12108 |
|---|---|
| Name | Taselisib |
| Groups | investigational |
| Description | Taselisib has been used in trials studying the treatment and basic science of LYMPHOMA, Breast Cancer, Ovarian Cancer, Solid Neoplasm, and HER2/Neu Negative, among others. |
| Synonyms | Taselisib |
| Categories |
|
| CAS number | 1282512-48-4 |
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 51001932 |
| ChEMBL | CHEMBL2387080 |
| Pharos | CHEMBL2387080 |
